Biomechanical anticoagulation by spherical platelets in extracorporeal systems
Rui Ji1, Yongjian Li1, Jiang Li2
1State Key Lab of Tribology, Department of Mechanical Engineering, Tsinghua University, Beijing 100084, China.
Summary
Platelet spherification offers a novel anticoagulation strategy for extracorporeal circuits, like hemodialysis. This method prevents blood coagulation by altering platelet mechanics, reducing bleeding risks associated with traditional heparin treatments.
Area of Science:
- Biomedical Engineering
- Hematology
- Materials Science
Background:
- Extracorporeal life support (e.g., hemodialysis) frequently encounters blood coagulation issues.
- Systemic heparin anticoagulation is standard but poses bleeding risks, especially in high-risk patients.
- Platelet activation and subsequent coagulation are sensitive to mechanical forces.
Purpose of the Study:
- To investigate platelet spherification as a novel anticoagulation strategy for extracorporeal systems.
- To elucidate the mechanical mechanisms underlying platelet activation and inhibition.
- To evaluate the efficacy and safety of platelet spherification in in vitro hemodialysis models.
Main Methods:
- Utilized molecular dynamics simulations to analyze integrin αIIbβ3 activation under different mechanical forces.
- Compared mechanical activation of discoid versus spherified platelets.
- Conducted in vitro hemodialysis experiments using spherified platelets to assess coagulation.
Main Results:
- Spherical platelets, when rolling, experience normal forces that induce rotation without activation.
- Sliding discoid platelets experience tangential forces that trigger integrin αIIbβ3 unfolding and activation.
- Platelet spherification significantly minimized coagulation in hemodialysis experiments without causing bleeding.
Conclusions:
- Platelet spherification is a viable strategy to prevent extracorporeal coagulation.
- This approach mitigates bleeding risks by avoiding systemic anticoagulation.
- Understanding platelet mechanobiology offers new avenues for anticoagulation therapies.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Formation of the Platelet Plug
10.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.7K
Structure and Function of Platelets
5.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
5.2K
Extrinsic and Intrinsic Pathways of Hemostasis
15.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.4K
Introduction to Hemostasis
16.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
16.8K


